FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.
Thompson Names Texas Health Official Head Of HHS Center For Faith-Based Initiatives.
Foundation Gives Duke $2M For Brain Tumor Research.
Democrats Say Bush Budget Neglects NSF And NASA.
Seattle Times, The Hutch Duel Over Five-Part Series.
NCI Offers Bibliography On Risk Communication.
SEER Program Expansion Through Cost-Sharing.
Toxicology Program Seeks Comment On Substances.
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- No need for a speculum? A new era of HPV screening
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Forty years after Chernobyl: Little evidence to show that radiation released from the accident increased cancers globally









